Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 206 Records) |
Query Trace: Lymphoma and TP53[original query] |
---|
Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 12 JCO2301053. Daniel Noerenberg, Franziska Briest, Cornelius Hennch, Kenichi Yoshida, Raphael Hablesreiter, Yasuhide Takeuchi, Hiroo Ueno, Annette M Staiger, Marita Ziepert, Fazila Asmar, Benjamin N Locher, Erika Toth, Thomas Weber, Rose-Marie Amini, Wolfram Klapper, Maria Bouzani, Viola Poeschel, Andreas Rosenwald, Gerhard Held, Elías Campo, Naveed Ishaque, Kostas Stamatopoulos, George Kanellis, Ioannis Anagnostopoulos, Lars Bullinger, Neta Goldschmidt, Pier Luigi Zinzani, Csaba Bödör, Richard Rosenquist, Theodoros P Vassilakopoulos, German Ott, Seishi Ogawa, Frederik Da |
The genetic landscape of histologically transformed marginal zone lymphomas. Cancer 2023 11 . Anqi Li, Hongmei Yi, Shijie Deng, Miao Ruan, Pengpeng Xu, Yujia Huo, Haiyang Lu, Xia Shen, Binsen Ouyang, Mingci Cai, Haimin Xu, Zhongyu Wang, Lei Zhang, Lingyan Zhu, Qi Peng, Yijin Gu, Jialing Xie, Yan Wang, Lei Dong, Zebing Liu, Chaofu Wa |
Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma. HemaSphere 2023 11 7 (11): e976. Madeleine R Berendsen, Diede A G van Bladel, Eva Hesius, Cristina Berganza Irusquieta, Jos Rijntjes, Annemiek B van Spriel, Ellen van der Spek, Johannes F M Pruijt, Leonie I Kroeze, Konnie M Hebeda, Sandra Croockewit, Wendy B C Stevens, J Han J M van Krieken, Patricia J T A Groenen, Michiel van den Brand, Blanca Scheij |
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group. Haematologica 2023 11 . Sylvain Carras, Alexia Torroja, Anouk Emadali, Emilie Montaut, Nicolas Daguindau, Adrian Tempescul, Anne Moreau, Emmanuelle Tchernonog, Anna Schmitt, Roch Houot, Caroline Dartigeas, Sarah Barbieux, Selim Corm, Anne Banos, Ludovic Fouillet, Jehan Dupuis, Margaret Macro, Joel Fleury, Fabrice Jardin, Clementine Sarkozy, Ghandi Damaj, Pierre Feugier, Luc Matthieu Fornecker, Cecile Chabrot, Veronique Dorvaux, Krimo Bouabdallah, Sandy Amorim, Reda Garidi, Laurent Voillat, Bertrand Joly, Nadine Morineau, Marie Pierre Moles, Hacene Zerazhi, Jean Fontan, Yazid Arkam, Magda Alexis, Vincent Delwail, Jean Pierre Vilque, Loic Ysebaert, Barbara Burroni, Mary Callanan, Steven Le Gouill, Rémy Gress |
Impact of ARID1A and TP53 mutations in pediatric refractory or relapsed mature B-Cell lymphoma treated with CAR-T cell therapy. Cancer cell international 2023 11 23 (1): 281. Yang Li, Yang Liu, Keyan Yang, Ling Jin, Jing Yang, Shuang Huang, Ying Liu, Bo Hu, Rong Liu, Wei Liu, Ansheng Liu, Qinlong Zheng, Yonghong Zha |
TP53 mutations predict for poor outcomes in patients with newly-diagnosed aggressive B cell lymphomas in the current era. Blood advances 2023 10 . Daniel J Landsburg, Jennifer Jd Morrissette, Sunita D Nasta, Stefan K Barta, Stephen J Schuster, Jakub Svoboda, Elise A Chong, Adam Ba |
Clinical Utility of Circulating Tumor DNA for Detecting Lung Cancer Mutations by Targeted Next-Generation Sequencing With Insufficient Tumor Samples. Journal of clinical laboratory analysis 2024 9 e25099. Yi Sun, Xu Zhang, Xinhua Yang, Jiangjun |
Dissecting the clinicopathological, genomic, and prognostic significance of ALK rearrangement in resected lung adenocarcinoma. The Journal of thoracic and cardiovascular surgery 2024 9 . Hang Cao, Wangyang Zhu, Huatao Tang, Chaoqiang Deng, Fangqiu Fu, Yuan Li, Yang Zhang, Haiquan Ch |
Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials. Leukemia 2024 9 . Mouhamad Khouja, Linmiao Jiang, Karol Pal, Peter James Stewart, Binaya Regmi, Martin Schwarz, Wolfram Klapper, Stefan K Alig, Nikos Darzentas, Hanneke C Kluin-Nelemans, Olivier Hermine, Martin Dreyling, David Gonzalez de Castro, Eva Hoster, Christiane Pott, |
Specific Mutation Predict Relapse/Refractory Diffuse Large B-Cell Lymphoma. Journal of blood medicine 2024 9 15 407-419. Jing Wang, Lei Tian, Weilong Zhang, Shuhan Tang, Wei Zhao, Yu Guo, Chaoling Wu, Yuansheng Lin, Xiaoyan Ke, Hongmei Ji |
Characterizing the Mutational Landscape of Diffuse Large B-Cell Lymphoma in a Prospective Cohort of Mexican Patients. International journal of molecular sciences 2024 9 25 (17): . Myrna Candelaria, Dennis Cerrato-Izaguirre, Olga Gutierrez, Jose Diaz-Chavez, Alejandro Aviles, Alfonso Dueñas-Gonzalez, Luis Malpi |
Evaluation of the novel International Association for the Study of Lung Cancer grading system in adenocarcinoma with spread through air space. Translational lung cancer research 2024 9 13 (8): 1862-1876. Kuan Xu, Yilv Lv, Tangbing Chen, Yuchen Han, Hanqing Huang, Hong Yu, Bo |
Association between low incidence of TP53 mutations and reduced early relapse rates in Uygur DLBCL. Annals of hematology 2024 8 . Mutibaier Mijiti, Chun Wang, Wenxin Tian, Qiping Shi, Fang Zhang, Renaguli Abulaiti, Xiaolong Qi, Zhen Kou, Cuicui Liu, Zengsheng Wang, Shunsheng Zhai, Li An, Qin Huang, Yang Shao, Guzailinuer Wufuer, Yan |
Single nucleotide polymorphism profiles of canine T-cell and null-cell lymphomas. Frontiers in veterinary science 2024 8 11 1439706. Sirintra Sirivisoot, Tanit Kasantikul, Somporn Techangamsuwan, Anudep Rungsipip |
Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients. Cancer drug resistance (Alhambra, Calif.) 2024 6 7 21. Gabriele Perrone, Luigi Rigacci, Giandomenico Roviello, Ida Landini, Alberto Fabbri, Lorenzo Iovino, Benedetta Puccini, Emanuele Cencini, Enrico Orciuolo, Monica Bocchia, Alberto Bosi, Enrico Mini, Stefania Nobi |
Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINE. Annals of hematology 2024 6 . Keshu Zhou, Tingyu Wang, Ling Pan, Wei Xu, Jie Jin, Wei Zhang, Yu Hu, Jianda Hu, Ru Feng, Ping Li, Zhougang Liu, Peng Liu, Hongmei Jing, Sujun Gao, Huilai Zhang, Kang Yu, Zhao Wang, Xiongpeng Zhu, Zimin Sun, Fei Li, Dongmei Yan, Jianyu Weng, Lina Fu, Liping Wang, Tommi Salmi, Kenneth Wu, Lugui Q |
Genomic landscape and distinct molecular subtypes of primary testicular lymphoma. Journal of translational medicine 2024 5 22 (1): 414. Weilong Zhang, Ping Yang, Yaru Yang, Shuozi Liu, Yongdeng Xu, Chaoling Wu, Jing Wang, Cuiling Liu, Hui Liu, Shuangshuang Li, Wei Huang, Hongmei Ji |
Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B-Cell Lymphoma: A Real-World, Multi-Center, Retrospective Cohort Study. Hematological oncology 2024 12 43 (1): e70017. Peiqi Zhao, Shu Zhao, Chen Huang, Yajun Li, Jiesong Wang, Junqing Xu, Lanfang Li, Zhengzi Qian, Wei Li, Shiyong Zhou, Lihua Qiu, Xianming Liu, Ying Chen, Yanan Jiang, Yanbin Zheng, Daoguang Chen, Hui Zhou, Yuhuan Gao, Qingyuan Zhang, Huilai Zha |
Comprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomes. International journal of cancer 2024 12 . Pooja Mittal, Francesca Battaglin, Yasmine Baca, Joanne Xiu, Alex Farrell, Shivani Soni, Jae Ho Lo, Lesly Torres-Gonzalez, Sandra Algaze, Priya Jayachandran, Karam Ashouri, Alexandra Wong, Wu Zhang, Jian Yu, Lin Zhang, Benjamin A Weinberg, Emil Lou, Anthony F Shields, Richard M Goldberg, John L Marshall, Sanjay Goel, Indrakant K Singh, Heinz-Josef Le |
TP53 Mutation Is the Only Robust Mutational Biomarker for Outcome Found in a Consecutive Clinical Cohort of Real-Word Patients With Primary Large B-Cell Lymphoma. European journal of haematology 2024 12 . Marie Fredslund Breinholt, Lone Schejbel, Anne Ortved Gang, Ib Jarle Christensen, Torsten Holm Nielsen, Lars Møller Pedersen, Estrid Høgdall, Peter Nørgaa |
[Clinical characteristics and prognostic analysis of diffuse large B-cell lymphoma with TP53 mutation]. Zhonghua yi xue za zhi 2024 12 104 (48): 4422-4426. Y Qin, J Xie, Y Q Wang, X Y Liu, L N Chen, X H He, J L Yang, S Y Zhou, P Liu, S Yang, L Gui, C G Zhang, Y K S |
Molecular Features of Diffuse Large B-Cell Lymphoma Associated With Primary Treatment Resistance. Hematological oncology 2024 11 43 (1): e70006. Allison M Bock, Kerstin Wenzl, Joseph P Novak, Matthew E Stokes, Melissa A Hopper, Jordan E Krull, Abigail R Dropik, Vivek Sarangi, Maria Ortiz, Nicholas Stong, C Chris Huang, Matthew J Maurer, Rebecca L King, Umar Farooq, Yucai Wang, Thomas E Witzig, Stephen M Ansell, Thomas M Habermann, James R Cerhan, Anita K Gandhi, Grzegorz Nowakowski, Anne J Nov |
Identification of Genomic Biomarkers of Disease Progression and Survival in Primary CNS Lymphoma. Blood advances 2024 11 . Huimin Geng, Shirley Shaoyi Mo, Lingjing Chen, Aishwarya Ballapuram, Mazie Tsang, Ming Lu, Andreas M Rauschecker, Kwun Wah Wen, Walter Patrick Devine, David A Solomon, James Louis Rubenste |
MYC-rearranged mature B-cell lymphomas in children and young adults are molecularly Burkitt Lymphoma. Blood cancer journal 2024 10 14 (1): 171. Sara Mato, Natalia Castrejón-de-Anta, Ariadna Colmenero, Lorenzo Carità, Julia Salmerón-Villalobos, Joan Enric Ramis-Zaldivar, Ferran Nadeu, Noelia Garcia, Luojun Wang, Jaime Verdú-Amorós, Mara Andrés, Nuria Conde, Verónica Celis, Maria José Ortega, Ana Galera, Itziar Astigarraga, Vanesa Perez-Alonso, Eduardo Quiroga, Aixiang Jiang, David W Scott, Elias Campo, Olga Balagué, Itziar Salaverr |
Genetic Risk Factors for Early-Onset Merkel Cell Carcinoma. JAMA dermatology 2024 1 . Noreen Mohsin, Devin Hunt, Jia Yan, Austin J Jabbour, Paul Nghiem, Jaehyuk Choi, Yue Zhang, Alexandra F Freeman, Jenna R E Bergerson, Stefania Dell'Orso, Kristina Lachance, Rima Kulikauskas, Loren Collado, Wenjia Cao, Justin Lack, Morgan Similuk, Bryce A Seifert, Rajarshi Ghosh, Magdalena A Walkiewicz, Isaac Browne |
Genetic and prognostic analysis of blastoid and pleomorphic mantle cell lymphoma: a multicenter analysis in China. Annals of hematology 2024 1 . Ping Yang, Shuo-Zi Liu, Chun-Yuan Li, Wei-Long Zhang, Jing Wang, Ying-Tong Chen, Sen Li, Cui-Ling Liu, Hui Liu, Qing-Qing Cai, Wei Zhang, Hong-Mei Ji |
Zanubrutinib plus R-CHOP for the treatment of newly diagnosed double-expressor lymphoma: A phase 2 clinical study. Cancer 2025 1 131 (1): e35697. Xia Yin, Qiang He, Dan Liu, Linna Xie, Hui Wang, Chunyan Chen, Chuanli Zhao, Ningning Shan, Shanshan Shi, Haichen Wei, Ji Ma, Ke Lu, Liang Wang, Yan Wang, Lijie Xing, Zengjun |
Retrospective analysis of clinical and molecular characteristics as prognostic factors in adult T-cell lymphoblastic lymphoma. American journal of cancer research 2025 1 14 (12): 5851-5862. Li Ma, Jing Wang, Jin Zhao, Meijing Zheng, Xiaolian Wen, Liping |
[The Prognostic Predictive Value of TP53 mutation Variant Allele Frequency in Diffuse Large B-Cell Lymphoma]. Zhongguo shi yan xue ye xue za zhi 2025 1 32 (6): 1719-1725. Ling-Long Zhang, Li An, Xiao-Long Qi, Abulaiti Renaguli, Zhen Kou, Wei Tan, Yu-Ling Nie, Abuduer Muhebaier, Yan |
[Clinical Features and Prognosis of Patients with Primary Extranodal Diffuse Large B-Cell Lymphoma]. Zhongguo shi yan xue ye xue za zhi 2025 1 32 (6): 1711-1718. Si Yi, Xia Li, Huan Tao, Hong-Bing Ma, Jie Ji, Yu Wu, Ting Niu, Yong-Qian J |
- Page last reviewed:Feb 1, 2024
- Content source: